By applying a sensitive method ddPCR, we were able to detect ESR1 hotspot mutations from serially collected plasma samples from a subset of patients with hormone receptor -positive/HER2-negative metastatic BC during palliative ETx. This evidence concerns the gene NR4A1 and breast cancer.